Exploratory Dose Ranging Study Assessing APH-1501 for the Treatment of Opioid Addiction

NCT03813095 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Addiction
Opioid Dependence
Opioid Withdrawal

Interventions

DRUG: APH-1501
DRUG: Placebo

Sponsor

Aphios